A Quote by Ron Wyden

In today's world, it is shortsighted to think that infectious diseases cannot cross borders. By allowing developing countries access to generic drugs, we not only help improve health in those nations, we also help ourselves control these debilitating and often deadly diseases.
If you take the burden of health care, of diseases off the backs of some other countries, it gives them a chance to use their own very limited resources in ways that help their people. And also there's a hopelessness associated with deadly diseases, that if that can be alleviated, people can build their own economies in their own countries and they'll be less reliant on the developed world for help.
As demonstrated by the emergence of the Mexican swine flu in the U.S., infectious diseases have little respect for borders; helping developing countries detect and deal with their diseases is the surest way for us to protect ourselves from new and potentially devastating epidemics.
We shall not defeat any of the infectious diseases that plague the developing world until we have also won the battle for safe drinking water, sanitation, and basic health care.
The National Institute of Allergy and Infectious Diseases is an institute of the National Institutes of Health that is responsible predominantly for basic and clinical research in the diagnosis, treatment and prevention of immunologic and infectious diseases.
Drug companies spend more on advertising and marketing than on research, more on research on lifestyle drugs than on life saving drugs, and almost nothing on diseases that affect developing countries only. This is not surprising. Poor people cannot afford drugs, and drug companies make investments that yield the highest returns.
Think about all kinds of infectious diseases, like mumps or measles or chicken pox. When a virgin population encountered those pathogens, it ravaged the population, and now they're childhood diseases, and eventually they won't even be that. That's our relationship with bacteria, going through time.
Beyond the borders of wealthy countries like the United States, in developing countries where most people in the world live, the impacts of climate change are much more deadly, from the growing desertification of Africa to the threats of rising sea levels and the submersion of small island nations.
I have seen this happen in recent years with regard to pharmaceuticals and vaccines, where, working together, we are improving access to medicines and vaccines for infectious diseases in the poorest countries.
During my tenure as Minister of Health of Ethiopia from 2005 to 2012, we achieved tremendous progress in tackling the many infectious diseases prevalent in resource-poor countries such as my own.
We cannot idealize technology. Technology is only and always the reflection of our own imagination, and its uses must be conditioned by our own values. Technology can help cure diseases, but we can prevent a lot of diseases by old-fashioned changes in behavior.
The covid-19 pandemic has demonstrated that infectious diseases know no borders.
Ensuring investment in health systems will not only help us manage HIV/AIDS, it will also support our efforts to prevent and treat other communicable and noncommunicable diseases as well as prevent and respond to future health emergencies.
New vaccines are being developed all the time, which could save many more lives and dramatically improve people's health. And this goes beyond the traditional burden of childhood infectious diseases.
My goals over the decade include to develop new drugs to treat intractable diseases by using iPS cell technology and to conduct clinical trials using it on a few patients with Parkinson's diseases, diabetes or blood diseases.
In low-income countries, the main problems you have is infectious diseases.
We start with an economic approach. We look at what are the greatest causes of death in the developing world, and what causes the largest amount of disability, which would prevent you from getting a job. A lot of those deaths start with diseases, diseases we don't get in such a great number in the United States.
This site uses cookies to ensure you get the best experience. More info...
Got it!